Somategrity Therapy: Business Model Generation of a New Therapeutic Approach to Somatic Disorders
Date Issued
2012
Date
2012
Author(s)
Wang, Tso-Liang
Abstract
The evidence-based mainstream medicine, though being the first choice for Taiwanese people when searching for medical solutions, can not fully satisfy quite a few people with somatic disorders and therefore brings the “anomalies” of normal science defined by Dr. Kuhn. The main purpose of this study is to build up an effective and feasible business model of a new therapeutic approach which is designed to reduce occurrence of the “anomalies”.
The study was conducted through an explorative analysis. It started with evaluating mainstream medicine by the concept of paradigm shift to identify five possible causes of occurrence of the “anomalies”: 1. uncertainty of diagnosis; 2. excessive dependence on imaging studies; 3. paying too much attention to focal lesions, neglecting whole picture of the human body; 4. inconsistency among management guidelines of different medical specialties; 5. overemphasizing allopathic remedies, neglecting structural imbalance － all of which trigger the possibility of medical innovation brought about by Somategrity Therapy(ST) developed by the author. ST is based on “three-level diagnosis of structural abnormalities” and corrects somatic dysfunctions through “re-alignment” and “core control”, etc.. It is complementary to and provides a good interface of cooperation with mainstream medicine for the purpose of solving the problem of “anomalies”.
The study used four perspectives and nine building blocks of Business Model Generation to describe the present status and challenges of ST. External environment was analyzed to identify the opportunities, threats and target customer segments; competitive analysis was performed to recognize the strength and weakness of ST as compared with its competitors; SWOT analysis was blended with the Four Actions Framework of Blue Ocean Strategy to find out the key successful factors and their potential challenges. In addition, three case studies focusing on products, education and services respectively were also analyzed to polish up the strategy of future development of ST.
The study revealed three key points of business model strategy of ST: 1. cooperate with mainstream medicine in evidence-based research and resource sharing; 2. design standardized and modulized operating procedures for target customer segments to reduce costs and increase service capacity; 3. set up comprehensive training programs and staff retention mechanisms to better standard operating procedures and quality control.
Overall, the analyses and design of this study can provide a practical framework to generate business models for future medical entrepreneurs who develop a new therapeutic approach as they intend to enter health care markets.
Subjects
Somategrity therapy
somatic dysfunction
somatic disorder
structural imbalance
Kuhn
paradigm shift
normal science
anomaly
new therapeutic approach
business model
Blue Ocean Strategy
SDGs
Type
thesis
File(s)![Thumbnail Image]()
Loading...
Name
ntu-101-P96744005-1.pdf
Size
23.32 KB
Format
Adobe PDF
Checksum
(MD5):860cc1bb71117087ae1eba3a430183ae